Table 2. Quality evaluation of plans to the H&N case under European protocol (EARL) and the own protocol (BIOGRAPH) with the highest available resolution.
| Image protocol for generating the prescription map |
P1 | P2 | P3 | |
|---|---|---|---|---|
| 0.97<Q<1.03 | BIOGRAPH | 88.4% | 73.5% | 80.4% |
| EARL | 64.8% | 84.2% | 82.8% | |
| 0.96<Q<1.04 | BIOGRAPH | 93.0% | 83.0% | 90.9% |
| EARL | 71.7% | 91.6% | 89.3% | |
| 0.95<Q<1.05 | BIOGRAPH | 97.0% | 90.9% | 95.1% |
| EARL | 74.1% | 96.1% | 93.3% | |
| QF | BIOGRAPH | 1.6% | 2.5% | 1.8% |
| EARL | 9.4% | 1.7% | 1.9% |
Percentage of voxels in BTs with quality index (Q) within 3%, 4% and 5% around 1 and the quality factor (QF) corresponding to the three plans (P1, P2 and P3) evaluated over the two dose prescription maps from both reconstruction protocols.